metoprolol has been researched along with Dyslipidemia in 3 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A total of 261 healthy individuals and 261 essential hypertension patients treated with metoprolol for 12 weeks were enrolled." | 3.88 | The Association of ADRB1 and CYP2D6 Polymorphisms With Antihypertensive Effects and Analysis of Their Contribution to Hypertension Risk. ( Chen, L; Deng, M; Wu, D; Xiao, T; Xie, S, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L | 2 |
| Xiao, T | 1 |
| Xie, S | 1 |
| Deng, M | 1 |
| Wu, D | 1 |
| Vaillant, F | 1 |
| Lauzier, B | 1 |
| Ruiz, M | 1 |
| Shi, Y | 1 |
| Lachance, D | 1 |
| Rivard, ME | 1 |
| Bolduc, V | 2 |
| Thorin, E | 2 |
| Tardif, JC | 2 |
| Des Rosiers, C | 2 |
| Drouin, A | 1 |
| Gillis, MA | 1 |
| Duquette, N | 1 |
| Thorin-Trescases, N | 1 |
| Frayne-Robillard, I | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Pharmacological Heart Rate Reduction on Visco-elastic Properties of the Arterial Wall (BRADYVASC)[NCT02584439] | Phase 3 | 30 participants (Anticipated) | Interventional | 2015-10-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for metoprolol and Dyslipidemia
| Article | Year |
|---|---|
The Association of ADRB1 and CYP2D6 Polymorphisms With Antihypertensive Effects and Analysis of Their Contribution to Hypertension Risk.
Topics: Adult; Antihypertensive Agents; Blood Glucose; Case-Control Studies; Cytochrome P-450 CYP2D6; Dyslip | 2018 |
Ivabradine and metoprolol differentially affect cardiac glucose metabolism despite similar heart rate reduction in a mouse model of dyslipidemia.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Benzazepines; Bradycardia; Cardiovascular Agents; D | 2016 |
Heart rate-associated mechanical stress impairs carotid but not cerebral artery compliance in dyslipidemic atherosclerotic mice.
Topics: Animals; Anti-Arrhythmia Agents; Apolipoproteins B; Atherosclerosis; Benzazepines; Carotid Arteries; | 2011 |